Amendment to third-party capital increase details
아이큐어
175250
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=2809
Risk-adjusted indicator based on 2809 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • SoluM Cosmetic: 18,858,802 Shares (3-year lock-up)
- • Shinshin Pharmaceutical: 2,901,353 Shares (1-year lock-up)
- • Deep Dive K-Beauty 2026 PEF: 2,417,794 Shares (1-year lock-up)
- • SoluM Cosmetic post-increase ownership: 30.55%
- • Previous CEO Choi Young-kwon ownership: 13.6%
AI Analysis Summary
Icure Pharmaceutical filed an amendment to its Material Fact Report regarding a paid-in capital increase. The primary change is the replacement of Deep Dive Partners with Deep Dive K-Beauty 2026 Private Equity Fund as a third-party assignee for 2,417,794 shares, with no change in the number of shares or other issuance terms. SoluM Cosmetic will receive 18,858,802 shares (3-year lock-up), and Shinshin Pharmaceutical 2,901,353 shares (1-year lock-up). Upon completion, SoluM Cosmetic will become the largest shareholder with 30.55% of shares, up from the previous CEO's 13.6%. The capital increase aims to normalize cash flow and resolve financial uncertainties from a past embezzlement case, including an 8B KRW tax liability. The company is pursuing a claim against the former CEO. The amendment itself is neutral, as it only clarifies the assignee without altering the core terms of the capital increase.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.